Can a glucose sensor and daily texts tame diabetes distress?
NCT ID NCT05941000
First seen Sep 22, 2026 · Last updated Sep 23, 2026 · Updated 1 time
Summary
Researchers are testing whether pairing a continuous glucose monitor with daily text messages about physical activity and mood can improve blood sugar control and reduce diabetes distress in adults with type 2 diabetes. Participants wear a glucose sensor and a Fitbit for 10 weeks. After a two-week baseline, they receive alternating two-week blocks of text-based support for either physical activity or mood. The study measures changes in time spent in the target blood sugar range, diabetes distress scores, and daily step counts.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- continuous glucose monitoring paired with text message-delivered behavior change support for physical activity and mood
- What this could lead to
- If it works, this approach could offer a low-burden way to help adults with type 2 diabetes manage blood sugar and emotional distress between clinic visits.
- What could go wrong
- The study is very small and early, so results may not hold for most people with type 2 diabetes. Text reminders and wearable devices do not help everyone, and some participants may find the daily messages easy to ignore.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
3 people
The number who actually took part.
- Started
-
Sep 2024
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
45 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 45 years or older * Diagnosis of type 2 diabetes * Suboptimal hemoglobin A1C (≥8.0%) * Positive screen for diabetes distress (Diabetes Distress Scale≥3.0) * Access to and capable of using a smart cellular phone * Ambulatory and never informed by clinician that it was not advisable/safe to participate in a low-intensity walking Exclusion Criteria: * Currently on dialysis * Inability to comply with study protocol during 2-week run-in * Currently using CGM * Does not speak English * Unavailable for follow-up * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwell Health - Institute of Health System Science
New York, New York, 10030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a diabetes kidney drug protect the kidneys in everyday care?
- A new pill aims at weight and blood sugar
- Diabetes nerve damage may disrupt the Brain's blood supply
- Can a portable ultrasound scan replace costly scans for muscle loss?
- Can mindfulness and yoga rewire diabetes habits?
- Can a vegan diet delivered online help people with type 2 diabetes?